(Q35005470)

5 August 2017

title

Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children (English)

1 reference

5 August 2017

1 reference

ChEBI release 2020-05-28

1 reference

Laurene H Wang

1

1 reference

5 August 2017

Andrew A Wiznia

2

1 reference

5 August 2017

Mobeen H Rathore

3

1 reference

5 August 2017

Gregory E Chittick

4

1 reference

5 August 2017

Saroj S Bakshi

5

1 reference

5 August 2017

Patricia J Emmanuel

6

1 reference

5 August 2017

Patricia M Flynn

7

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Antimicrobial Agents and Chemotherapy

5 August 2017

published in

1 reference

5 August 2017

volume

48

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

183-191

1 reference

Prototype trial design for rapid dose selection of antiretroviral drugs: an example using emtricitabine (Coviracil).

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310155

The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310155

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310155

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310155

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310155

Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310155

Reproductive toxicology profile of emtricitabine in mice and rabbits

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310155

Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310155

10.1128/AAC.48.1.183-191.2004

26 October 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference